Legal Representation
Attorney
Rachelle A. Dubow, Esq.
USPTO Deadlines
Next Deadline
2008 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-01-28)
Due Date
January 28, 2031
Grace Period Ends
July 28, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
50 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jan 28, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Jan 28, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Jan 8, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
Jan 8, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
Jan 7, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jan 3, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
Dec 18, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
Dec 18, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
Sep 13, 2024 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
Jul 2, 2024 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Jul 2, 2024 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Jul 2, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 2, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jun 28, 2024 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
Jun 28, 2024 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
Jun 27, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Jun 20, 2024 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
Dec 12, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Dec 8, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Dec 8, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Dec 8, 2023 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Jun 22, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jun 20, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Jun 20, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Jun 20, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jan 5, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jan 3, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Jan 3, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Jan 3, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 5, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 1, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Jul 1, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Jul 1, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
May 19, 2022 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
Jan 4, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Nov 9, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Nov 9, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Oct 20, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Oct 7, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Oct 6, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Oct 5, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Oct 5, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Sep 9, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Sep 9, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Sep 9, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Apr 5, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Apr 5, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Apr 5, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Apr 2, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jan 8, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 001
Biological products, namely, DNA circle, DNA primers, linear DNA and buffers for use in research and development of pharmaceuticals and for manufacture of pharmaceuticals; Biological products, namely, antibodies, multi-specific antibodies, antibody fragments, proteins, chimeric proteins, drug conjugates and enzymes, for use in research and development of pharmaceuticals and for manufacture of pharmaceuticals
First Use Anywhere:
Nov 7, 2024
First Use in Commerce:
Nov 7, 2024
Class 005
Chemical preparations for gene delivery pharmaceuticals for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for therapeutic analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; Gene therapy and prophylactic products, namely, gene delivery pharmaceuticals for the treatment of genetic or cell based conditions; Pharmaceutical preparations containing nucleic acid sequences that encode monoclonal antibodies for the treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Pharmaceutical compositions for the prevention and treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Biological preparations for the treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Nucleic acid sequences for medical purposes; Pharmaceutical compositions, namely, a nucleotide sequence that encodes an antigen, such as a DNA plasmid having an antigen encoding sequence and like DNA, for the prevention and treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Pharmaceutical preparations for human use for the treatment and prevention of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; pharmaceutical preparations for human and veterinary use, namely, antibiotics, antifungals and anti-virals
First Use Anywhere:
Nov 7, 2024
First Use in Commerce:
Nov 7, 2024
Class 010
Medical apparatus for the administration of biopharmaceuticals and vaccines, namely, drug delivery devices and systems being pulse and waveform generators for the delivery of sub-dermal or intramuscular or intravenous drugs; medical devices, namely, pulse and waveform generators for electroporation mediated administration of drugs to humans and animals; delivery systems comprised of pulse and waveform generators for the delivery of sub-dermal or intramuscular or intravenous drugs for administration of biopharmaceuticals and vaccines for the preventive or treatment of disease in humans and animals; handheld medical systems and devices comprised of pulse and waveform generators using electroporation for the prevention or treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders in humans and animals; handheld clinical delivery systems and devices comprised of pulse and waveform generators for the application of electrical fields in tissue, in particular muscle and skin, in conjunction with the administration of biopharmaceuticals
First Use Anywhere:
20231200
First Use in Commerce:
20231200
Classification
International Classes
001
005
010